GI Dynamics, Inc. is pioneering the development and commercialization of effective, non-surgical treatments targeting the large and growing global patient populations with type 2 diabetes and obesity.

The company’s flagship product, the EndoBarrier®, is a novel, non-surgical device proven to lower blood glucose levels and promote weight loss in diabetic patients and/or obese patients during the implant period. GI Dynamics currently markets the EndoBarrier in select regions in Europe, South America and Australia and is planning near-term commercial expansion into additional European countries.

Contact Info

One Maguire Road, Lexington, MA, 02421
Tel: 781-357-3300

Polaris Lead

Amir Nashat

Follow on TwitterVisit our Twitter page
Social Media